Have you seen the latest news and insights on Cystic Fibrosis News Today?

Cystic Fibrosis Weekly Update Contents: Enrollment Stopped in 2 Trials of Treatments for CF Lung Infections ReCode Therapeutics Raises $80M to Boost Development of CF Therapies Enrollment Stopped in 2 Trials of Treatments for CF Lung Infections Apr 03, 2020 07:00 am | Joana Carvalho, PhD Savara Pharmaceuticals has stopped patient enrollment into two of its ongoing clinical trials in cystic fibrosis (CF) patients — AVAIL and ENCORE — for safety reasons due to the COVID-19 pandemic. Steps will also be taken to ensure that those already enrolled in both studies continue to receive treatment and possibly keep with site visit […] The post Enrollment Stopped in 2 Trials of Treatments for CF Lung Infections appeared first on Cystic Fibrosis News Today. Read More ReCode Therapeutics Raises $80M to Boost Development of CF Therapies Apr 02, 2020 07:00 am | Patricia Inacio, PhD ReCode Therapeutics has raised $80 million in Series A financing to support the preclinical development of its lead targeted RNA therapy for cystic fibrosis (CF). The funding also will be used to support the development of RNA therapies for primary ciliary dyskinesia (PCD), a hereditary condition that impairs the function of lung cilia — the fingerlike projections in […] The post ReCode Therapeutics Raises $80M to Boost Development of CF Therapies appeared first on Cystic Fibrosis News Today. Read More Recent News MRT5005 Gets FDA Rare Pediatric Disease Status as Adult Trial Faces Delay Due to COVID-19 I’m Holding a Funeral for My Former Self Vertex Assures Supply of CF Therapies, But COVID-19 Likely to Affect Trials Trikafta Therapy Prompted the Most Unexpected Emotions Pulmonary Fibrosis Patient Spearheads Lung Transplant Foundation to Help Others